Doctor Geonwoo Park
Daejeon Wellness Hospital, Head of the Hemato-Oncology Department
TEL. 02-538-5886
FAX. 02-538-5887
E-mail.
Academic Background
- Yeungnam University College of Medicine, Medical Center Intern
- Gangnam St. Mary’s Hospital, Internal Medicine Resident
- Public Health Doctor (Gimcheon Medical Center, Affiliated
- Hospital of Qingdao University)
- Yeouido St. Mary’s Hospital, Seoul St. Mary’s Hospital, Oncology Clinical Instructor
- Acquired specialization in hemato-oncology internal medicine department
- Master of Medicine
Medical Career
- 2011 – 2014 Daegu Fatima Hospital, Internal Medicine Manager
- 2014 – Present Daejeon Wellness Hospital, Head of the Oncology Department
- The Korean Association of Internal Medicine, Full Member
- Korean Cancer Association, Full Member
- Korean Society of Medical Oncology, Full Member
- Korean Cancer Study Group, Full Member
- Korean Society for Hospice and Palliative Care, Full Member
Advisory Career
- Apr. 2016 – June 2016 Awair Advisor
- Jan. 2017 – Dec. 2017 IM Healthcare Advisor
- May 2017 – Present Blue Point Partners Medical Advisor
- Apr. 2018 – Present CytoDx Medical Director
- Jan. 2019 – Present DAYLI Partners Medical Advisor
Investment Experience
- 2015 KOSDAQ Listed Company “N”
- 2015 – 2016 Unlisted Company
- BIOINFRA
- Kainos Medicine
- IM Healthcare
- 2017 Establishment of Malaysian foreign branch (overseas medical entry)
- 2017 – Present
- Remedy
- RevoSketch
- CytoDx
- BIORCHESTRA
- Medibloc
- Blue Point Partners
- Ultra V
- TE Bios
- Jan. 2019 Daily Golden Time Healthcare Fund
- Established Doctors Healthcare Investment Research Group
- Around 400 member doctors, as well as university professors, accelerators, VCs, etc.
- Nov. 2017 Remedy angel investment
- May 2018 MUNE (syringe disposal medical device) angel investment
- July 2018 Kmedisys (arthroscope business) angel investment
- Jan. 2019 Established private equity fund with DAYLI Partners
- Completed Qualified Angel Investment Course
Other Activities
- KAIST Student Venture Team Mentoring
- Lead clinical application and research of healthcare products
Languages
- Korean and English